Ben has spent his career rethinking how diagnostics are made and used. He’s founded and led multiple public and private ventures, creating technologies that have reshaped everyday clinical practice. Among them is Genedrive®, one of the world’s first true point-of-care molecular platforms, now setting a new standard of care across the NHS. As CEO of ReadyGo, Ben drives the company’s vision to make testing simpler, smarter, and more accessible—overseeing daily operations, strategic delivery, and the next generation of product innovation.